Ontology highlight
ABSTRACT: Background
Remdesivir is a monophosphoramidate prodrug of an adenosine analog, and it has a broad-spectrum antiviral activity against paramyxoviruses, flaviviruses, and coronaviruses. Remdesivir is associated with decreased hospital stay and improved outcomes in coronavirus- disease 2019 (COVID-19).Methodology
Of 846 suspected COVID-19 patients admitted to the hospital, 612 SARS-CoV-2 nasopharyngeal RT-PCR positive patients were evaluated for enrollment in this prospective cohort study. 159 RT-PCR positive patients were given remdesivir. Their clinical, biochemical parameters, hospital stay, and outcomes related to morbidity and mortality were followed.Results
Out of the 159 patients, 141 recovered after remdesivir use. The Chi-square test for independence examined
SUBMITTER: Malik MI
PROVIDER: S-EPMC8823973 | biostudies-literature | 2022 Mar
REPOSITORIES: biostudies-literature